Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ITPR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CFAP74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RNF151 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC20A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTTY15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL13A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPFFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGCR14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF599 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on